Prevalance of Premenstrual Syndrome Among Women of Pakistan

Authors

  • Saeedullah Channa
  • Shadman Nasreen
  • Hina Waheed
  • Amber Yasmin

Keywords:

Premenstrual Syndrome, Prevalence, Pakistan, depression, DSM criterion IV

Abstract

Objectives: To find out the prevalence of Premenstrual Syndrome amongst women of Pakistan

Materials and Methods: A cross sectional self reported survey was conducted from 1st August 2011 till 31st January 2012 by collecting data from different cities that is Islamabad , Quetta , Karachi , Multan , Hyderabad. 382 participants from various hospitals, universities, colleges, shopping malls filled up a self administered closed ended questionnaire designed on DSM IV.11 premenstrual syndrome symptoms based on occurrence and severity were used for diagnosis. If 4 of them were positive then a female was labeled to be suffering from Premenstrual Syndrome (PMS)

Results: The prevalence of premenstrual syndrome was 191(55%). The ascending order of prevalence of symptoms occurring in PMS was depression, tension, labile mood, bloating, swollen breast and headache.

Conclusion: Premenstrual syndrome is a common problem in women of reproductive age group. There is a need for simple diagnostic methods for early detection. Social media and physicians should provide education to reduce its prevalence and improve the quality of life in the affected females

References

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)

ICD-10 (World Health Organization (WHO), 1992

Dickerson LM, Mazyck PJ, Hunter MH .Premenstrual syndrome.. Am Fam Physician. 2003 Apr 15;67(8):1743-52.

Rapkin AJ, MikacichJA.Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents Paediatr Drugs. 2013;15(3):191-202. doi: 10.1007/s40272-013-0018-4.

Tabassum S, Afridi B, Aman Z, Tabassum W, Durrani R.Premenstrual syndrome: Frequency and severity in young college girls. J Pak Med Assoc 2005;55:546-9.

Qiao M, Zhang H, Liu H, Luo S, Wang T, Zhang J et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. Eur J ObstetGynecolReprod Biol. 2012 May;162(1):83-6. doi: 10.1016/j. ejogrb. 2012.01.017.

Dennerstein L, Lehert P, Heinemann K. Global study of women's experiences of premenstrual symptoms and their effects on daily life.Menopause Int. 2011;17(3):88-95. doi: 10.1258/mi.2011.011027.

Cirillo PC, Passos RB, Bevilaqua MC, López JR, Nardi AE .Bipolar disorder and Premenstrual Syndrome or Premenstrual Dysphoric Disorder comorbidity: a systematic review. Rev Bras Psiquiatr. 2012 Dec;34(4):467-79

Raja SN, Ferhan M, Stanton WR, McGee R. Prevalence and correlates of the premenstrual syndrome in adolescence. J Am Acad Child Adolesc Psychiatry 1992;31:783-9.

McHichi AK, Tahiri SM, Moussaoui D, Kadri N. Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca. Encephale. 2002;28:525-30.

Choi D, Lee DY, Lehert P, Lee IS, Kim SH, Dennerstein L. J. The impact of premenstrual symptoms on activities of daily life in Korean women. PsychosomObstetGynaecol. 2010;31(1):10-15. doi: 10.3109/0167482090 3573920.

Buttner MM, Mott SL, Pearlstein T, Stuart S, Zlotnick C, O'Hara MW.Examination of premenstrual symptoms as a risk factor for depression in postpartum women. Arch Women Ment Health. 2013 ;16(3):219-25. doi: 10.1007/s00737-012-0323-x.

Hamaideh SH, Al-Ashram SA, Al-Modallal H. Premenstrual syndrome and premenstrual dysphoric disorder among Jordanian women. J PsychiatrMent H e a l t h N u r s . 2 0 1 4 ; 2 1 ( 1 ) : 6 0 - 8 . d o i : 10.1111/jpm.12047.

Hoyer J, Burmann I, Kieseler ML, Vollrath F, Hellrung L, Arelin K et al. Menstrual cycle phase modulates emotional conflict processing in women with and without premenstrual syndrome (PMS)-- a pilot study. J. PLOS One. 2013; 24:8(4):e597-80. doi: 10.1371/journal.pone.0059780.

Reed SC, Levin FR, Evans SM.Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).. HormBehav. 2008;54(1):185-93. doi: 10.1016/j.yhbeh.2008.02.018.

Dennerstein L, Lehert P, Bäckström TC, Heinemann K.Premenstrual symptoms, severity, duration and typology: an international cross-sectional study. Menopause Int . 2009;15(3):120 - 6 . doi: 10.1258/mi.2009.009030.

Akmal N, Akhtar N, Attique R,Raana G. Prevalence of pre-menstrual syndrome in young girls. Ann King Edward Med Coll. 2006 ; 12(2): 237-8.

Khakwani M, Zaidi HI, Tariq N. Adolescent age group; normal menstrual cycle and menstrual disorders. Professional Med J. 2006 ; 13(4): 543-9.

Shershah S, Morrison JJ, Jafarey S.Prevalence of premenstrual syndrome in Pakistani women.JPMA 2007;12(2):354-9

Helvacioglu A, Yeoman RR, Hazelton JM, Aksel S. Premenstrual syndrome and related hormonal changes. Long-acting gonadotropin releasing hormone agonist treatment. J Reprod Med. 1993;38(11):864-70

Giannini AJ, Melemis SM, Martin DM, Folts DJ. Symptoms of premenstrual syndrome as a function of betaendorphin: two subtypes ProgNeuropsychopharmacolBiol Psychiatry.1994;18(2):321-7.

Meczekalski B, Warenik-Szymankiewicz A.Beta-endorphin--physiologic role and menstrual cycle disorders. Ginekol Pol. 1995;66(10):586-95

Taskin O, Gökdeniz R, Yalcinoglu A, Buhur A, Burak F, Atmaca R et al Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome. Hum Reprod. 1998 ;13(9):2402-5.

Straneva PA, Maixner W, Light KC, Pedersen CA, Costello NL, Girdler SS. Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder. Health Psychol. 2002;21(4):358-67.

Jacobs S.J. Micronutrients and the premenstrual syndrome: the case for calcium. Am ColNutr. 2000;19(2):220-7.

Marjoribanks J, Brown J, O'Brien PM, Wyatt K.Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013;7;6:CD001396. d o i : 10.1002/14651858.CD001396.

Brown J, O' Brien PM, Marjoribanks J, Wyatt K.Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst R e v . 2009;15: (2): CD001396. doi: 10.1002/14651858.CD001396.

Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. Am Fam Physician. 2003; 15:67(8):1743-52.

Bloch M, Schmidt PJ, RubinowDR .Premenstrual syndrome: evidence for symptom stability across cycle. Am J Psychiatry. 1997;154(12):1741-6.

Limosin F, Ades. Psychiatric and psychological aspects of premenstrual syndrome. J.Encephale. 2001;27(6):501-8

Downloads

Published

2013-06-20

How to Cite

Channa, S. ., Nasreen, S. ., Waheed, H. ., & Yasmin, A. . (2013). Prevalance of Premenstrual Syndrome Among Women of Pakistan. Journal of Bahria University Medical and Dental College, 3(1), 24–29. Retrieved from https://jbumdc.bahria.edu.pk/index.php/ojs/article/view/50

Issue

Vol. 3 No. 1 (2013): Volume 3 Issue 1

Section

Original Articles

License

Copyright (c) 2013 Saeedullah Channa, Shadman Nasreen, Hina Waheed, Amber Yasmin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0